Lixte Biotechnology Holdings Inc. (LIXT)
$3.71
$-0.60
(-13.92%)
As on 02-Sep-2026 09:30EDT
Market cap
$125 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
3.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-1.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-1.5
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.7
-
Face value
--
-
Shares outstanding
17,386,450
10 Years Aggregate
CFO
$-25.27 Mln
EBITDA
$-34.42 Mln
Net Profit
$-35.48 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lixte Biotechnology Holdings (LIXT)
| -5.6 | -17.2 | -48.5 | -16.6 | 13.9 | -32.0 | -11.1 |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lixte Biotechnology Holdings (LIXT)
| 93.6 | -13.5 | -53.8 | -57.1 | -62.5 | -22.2 | -27.0 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lixte Biotechnology Holdings (LIXT)
|
3.7 | 125.4 | 0.0 | -8.7 | -- | -51.4 | -- | 3.3 |
| 86.5 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 271.1 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 74.0 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 59.1 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 110.8 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 371.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 542.6 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 593.4 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 355.2 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Lixte Biotechnology Holdings (LIXT)
Lixte Biotechnology Holdings, Inc. develops utility-scale mobile energy storage systems on providing transportable solutions. It offers plug-and-play battery storage systems integrated into specially designed and patent-pending mobile energy storage... systems and docking systems. The company's products include Traveler, a mobile battery energy storage system offering utility-scale power with 1 MW output and 2 MWh capacity; Voyager Falcon, an energy storage system for peak shaving, load shifting, and renewable integration projects; Voyager Eagle, a battery storage solution for rapid response grid services and demanding industrial applications; and Voyager Hawk, a battery storage solution for construction sites, events, and emergency backup. Its products are used for various applications, including peak shaving, wing and solar, power as a service, AI and data centers, rentals, mining, cannabis production, ski resorts oil and gas, utilities, commercial and industrial, EV charging and infrastructure, government, and communities and events. Lixte Biotechnology Holdings, Inc. is based in Waterbury, Vermont. Read more
-
President, CEO & Chairman of the Board of Directors
Mr. Bastiaan van der Baan M.Sc.
-
President, CEO & Chairman of the Board of Directors
Mr. Bastiaan van der Baan M.Sc.
-
Headquarters
Waterbury, VT
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Lixte Biotechnology Holdings (LIXT)
What is the current share price of Lixte Biotechnology Holdings Inc (LIXT) Today?
The share price of Lixte Biotechnology Holdings Inc (LIXT) is $3.71 (NASDAQ) as of 02-Sep-2026 09:30 EDT. Lixte Biotechnology Holdings Inc (LIXT) has given a return of 13.91% in the last 3 years.
What is the current PB & PE ratio of Lixte Biotechnology Holdings Inc (LIXT)?
Since, TTM earnings of Lixte Biotechnology Holdings Inc (LIXT) is negative, P/E ratio is not available.
The P/B ratio of Lixte Biotechnology Holdings Inc (LIXT) is 3.33 times as on 28-Aug-2026, a 36 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-31.66 |
19.69 |
2024 |
-1.27 |
5.52 |
2023 |
-1.04 |
1.32 |
2022 |
-0.13 |
0.16 |
2021 |
-0.24 |
0.34 |
What is the 52 Week High and Low of Lixte Biotechnology Holdings Inc (LIXT)?
The 52-week high and low of Lixte Biotechnology Holdings Inc (LIXT) are Rs 8.38 and Rs 2.36 as of 04-Sep-2026.
What is the market cap of Lixte Biotechnology Holdings Inc (LIXT)?
Lixte Biotechnology Holdings Inc (LIXT) has a market capitalisation of $ 125 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Lixte Biotechnology Holdings Inc (LIXT)?
Before investing in Lixte Biotechnology Holdings Inc (LIXT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.